Foetal Cell Transplantation for Parkinson’s Disease: Focus on Graft-Induced Dyskinesia
Transplantation of dopamine- (DA-) rich foetal ventral mesencephalic cells emerged as a promising therapy for Parkinson’s disease (PD), as it allowed significant improvement of motor symptoms in several PD patients in open-label studies. However, double-blind clinical trials have been largely disapp...
Saved in:
| Main Authors: | Elisabetta Tronci, Camino Fidalgo, Manolo Carta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Parkinson's Disease |
| Online Access: | http://dx.doi.org/10.1155/2015/563820 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
by: Bruno Lopes SANTOS-LOBATO, et al.
Published: (2020-04-01) -
Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
by: John C. P. Piedad, et al.
Published: (2012-01-01) -
Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study
by: Bruno Lopes Santos-Lobato, et al.
Published: (2023-05-01) -
Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
by: Nayron Medeiros Soares, et al.
Published: (2023-01-01) -
A2A Receptor Antagonism and Dyskinesia in Parkinson’s Disease
by: Micaela Morelli, et al.
Published: (2012-01-01)